Copyright
©The Author(s) 2023.
World J Diabetes. Nov 15, 2023; 14(11): 1643-1658
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1643
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1643
Figure 2 Effects of vascular endothelial growth factor B on body weight and blood glucose level.
A: Body weight from the 16th to the 24th wk; B: Food intake energy from the 16th to the 24th wk; C: Fasting blood glucose from the 16th to the 24th wk; D: PBG from the 16th to the 24th wk; E and F: Oral glucose tolerance test and area under the curve (AUC); G and H: Intraperitoneal insulin tolerance test and AUC; I: GHb; J: Serum glucose; K: Serum insulin; L: Serum glucagon. aP < 0.05 vs standard diet; bP < 0.05 vs high-fat diet-WT; cP < 0.05 vs Con. HFD: High-fat diet; AAV: Adeno-associated virus; SD: Standard diet.
- Citation: Li YQ, Zhang LY, Zhao YC, Xu F, Hu ZY, Wu QH, Li WH, Li YN. Vascular endothelial growth factor B improves impaired glucose tolerance through insulin-mediated inhibition of glucagon secretion. World J Diabetes 2023; 14(11): 1643-1658
- URL: https://www.wjgnet.com/1948-9358/full/v14/i11/1643.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i11.1643